CBIO
CRESCENT BIOPHARMA, INC.
NASDAQ · Healthcare · Biotechnology · US
$13.82
+5.82%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$13.76
From 52W high−48.78%
Volume172845.00
Market cap$513.33M
P/E (TTM)—
P/S (TTM)43.2x
Div yield—
Key dataNov 4, 2026
Open
$13.76
From 52W high
−48.78%
Volume
172845.00
Market cap
$513.33M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−2.1x
P/E (TTM)
—
RSI (14)
45.4
MomentumView details →
1D Return
+5.82%
YTD Return
+11.89%
Similar companies
Latest newsMore news →
Crescent Biopharma approved an inducement award of options to purchase 11,775 ordinary shares for one non-executive employee.1d agoCrescent Biopharma approved options to purchase an aggregate of 81,525 ordinary shares for six non-executive employees as inducement awards.29d agoCrescent Biopharma received FDA clearance of its IND application for CR-002, a PD-L1-targeted topoisomerase inhibitor ADC for the treatment of solid tumors.30d ago